F&C Investment Trust

F&C Investment Trust

F&C Investment Trust was founded in 1868 as the Foreign & Colonial Government Trust, originator of the collective investment model, with an initial remit to invest in emerging-market bonds including Brazil. Today it operates under the management of Columbia Threadneedle Investments, having transferred from BMO Global Asset Management in 2016 (per Altss research), and remains governed by an independent non-executive board chaired by Beatrice Hollond. The trust has moved from those 19th-century sovereign bonds to holding shares in Amazon and Tesla alongside stalwarts like Unilever and GlaxoSmithKline. Niven runs a globally diversified portfolio across listed equities, private equity funds, and emerging-market exposures. The trust's target asset-class mix spans major developed-market stock exchanges, Chinese and Latin American growth stories, and a curated sleeve of third-party private equity vehicles. Portfolio concentration is deliberately low — over 400 companies — with the objective of producing steady capital appreciation and income. The fund uses gearing to amplify returns in favorable conditions, a structural lever not available to many competing structures. A 4-for-1 share split executed in May 2026 adjusted the nominal share price without altering net asset value. Beyond Niven, the board draws directors from Ruffer, BlackRock, CVC Capital Partners, and the Confederation of British Industry, adding multi-asset, macro, and operational expertise. The trust does not report select professional headcount, and total assets are not publicly disclosed. It is a member of the Association of Investment Companies and holds the AIC Dividend Hero designation for over 50 years of consecutive annual dividend increases, a record that places it among the most persistent income compounders in the London market. F&C's regulatory architecture as an investment trust gives it a closed-end structure: the manager cannot be forced to sell assets to meet redemptions, an advantage over open-ended funds during market dislocations. The trust's board — not the fund manager — controls gearing levels and can repurchase shares at a discount to net asset value, aligning governance with patient capital. This legal form, combined with a mandate extending to private equity funds, means F&C can tolerate illiquidity that open-ended peers structurally cannot.